Analyst firms · Cantor Fitzgerald · CAPR

Cantor Fitzgerald CAPR price target and rating history

Capricor Therapeutics Inc. (CAPR) · Health Care

Cantor Fitzgerald rates Capricor Therapeutics Inc. (CAPR) Overweight with a $28 price target, as of its latest action on Aug 14, 2026. It has published 3 rating actions on CAPR since January 2024, including 1 upgrade and 1 downgrade. Across 6 firms with a CAPR price target in the last 12 months, the median target is $23. Cantor Fitzgerald's $28 is 22% above that.

Current rating
Overweight
Price target
$28
Median target, all firms
$23
Actions on CAPR
3

Cantor Fitzgerald price target on CAPR

$28$16$3.5020252026
Cantor Fitzgerald price target on CAPR, each point a stated target, January 2024 to August 2026.

Every Cantor Fitzgerald rating on CAPR

How other firms rate CAPR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
B. Riley SecuritiesBuy$21Sep 14, 2026
Piper SandlerOverweight$25Sep 1, 2026
OppenheimerOutperform$54Aug 25, 2026
Cantor FitzgeraldOverweight$28Aug 14, 2026
Maxim GroupHoldJul 30, 2026
H.C. WainwrightNeutralJul 30, 2026
Ladenburg ThalmannNeutralJul 30, 2026
Alliance Global PartnersNeutral$7Jul 28, 2026
Roth CapitalNeutral$7Jul 27, 2026

Questions about Cantor Fitzgerald and CAPR

What is Cantor Fitzgerald's price target for CAPR?
Cantor Fitzgerald's latest stated price target for Capricor Therapeutics Inc. (CAPR) is $28, from its action on Aug 14, 2026.
What is Cantor Fitzgerald's rating on CAPR?
Cantor Fitzgerald rates CAPR Overweight, a bullish rating, as of Aug 14, 2026.
When did Cantor Fitzgerald last change its view on CAPR?
On Aug 14, 2026, Cantor Fitzgerald upgrades to Overweight from Neutral, price target $28.
How does Cantor Fitzgerald's CAPR target compare with other analysts?
Across 6 firms with a CAPR price target in the last 12 months, the median target is $23. Cantor Fitzgerald's $28 is 22% above that.

More CAPR rating histories

All Cantor Fitzgerald ratingsCAPR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.